ACOR Bio "buy the rumor sell the news" event
ACORDA THERAPEUTICS, INC. NASDAQ:ACOR
Future Catalyst:
October 2018 10/31/2018
Phase 2 data likely due October 2018.
Market cap: 942M. Float: 46M
Company Notes – Negative income with poor performance. 4 Products non of which has passed P3.
Watching for volume to push stock through consolidation and climb into the Phase 2 data results and sell off. Investors have little hope for this stock and any remaining longs underwater will be looking for any run up into this catalyst as an opportunity to sell.